-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Oral and Poster Abstracts

Saturday, December 5, 2015

7:30 AM-9:00 AM

Disorders of Platelet Number or Function

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Engraftment and Disease Activity

Health Services and Outcomes Research – Non-Malignant Conditions

9:30 AM-11:00 AM

Hematopoiesis: Epigenetic, Transcriptional and Translational Control

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myeloproliferative Syndromes: Clinical

Clinical Allogeneic Transplantation: Results

12:00 PM-1:30 PM

Hemoglobinopathies, Excluding Thalassemia – Clinical

Disorders of Platelet Number or Function

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Myelodysplastic Syndromes – Clinical Studies

Adoptive Immunotherapy

2:00 PM-3:30 PM

Disorders of Platelet Number or Function

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

4:00 PM-5:30 PM

Blood Coagulation and Fibrinolytic Factors

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myelodysplastic Syndromes – Basic and Translational Studies

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

Clinical Allogeneic Transplantation: Results

5:30 PM-7:30 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia – Clinical

Granulocytes, Monocytes and Macrophages

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Platelet Activation and Biochemistry

Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Antithrombotic Therapy

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Epigenetic, Transcriptional and Translational Control

Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Bone Marrow Failure

Chromosomal Rearrangements and DNA Repair

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Hodgkin Lymphoma: Biology, excluding Therapy

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes – Basic and Translational Studies

Myelodysplastic Syndromes – Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Malignant Stem and Progenitor Cells

Experimental Transplantation: Basic Biology, Engraftment and Disease Activity

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

Adoptive Immunotherapy

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Chemical Biology and Experimental Therapeutics

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases

Sunday, December 6, 2015

7:30 AM-9:00 AM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Chromosomal Rearrangements and DNA Repair

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Myeloma: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

9:30 AM-11:00 AM

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Blood Coagulation and Fibrinolytic Factors

Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

9:30 AM-11:15 AM

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

12:00 PM-1:30 PM

Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion

Hematopoietic Stem and Progenitor Biology

Acute Lymphoblastic Leukemia: Clinical Studies

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Gene Therapy and Transfer

Health Services and Outcomes Research – Malignant Diseases

4:30 PM-6:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Disorders of Coagulation or Fibrinolysis

Bone Marrow Failure

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Myeloid Leukemia: Clinical Studies

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myelodysplastic Syndromes – Basic and Translational Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

6:00 PM-8:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia – Clinical

Granulocytes, Monocytes and Macrophages

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Platelet Activation and Biochemistry

Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Antithrombotic Therapy

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Epigenetic, Transcriptional and Translational Control

Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Bone Marrow Failure

Chromosomal Rearrangements and DNA Repair

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Hodgkin Lymphoma: Biology, excluding Therapy

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes – Basic and Translational Studies

Myelodysplastic Syndromes – Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Malignant Stem and Progenitor Cells

Experimental Transplantation: Basic Biology, Engraftment and Disease Activity

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

Adoptive Immunotherapy

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Chemical Biology and Experimental Therapeutics

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases

Monday, December 7, 2015

7:00 AM-8:30 AM

Regulation of Iron Metabolism

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Platelet Activation and Biochemistry

Blood Coagulation and Fibrinolytic Factors

Antithrombotic Therapy

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Myeloid Leukemia: Clinical Studies

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Basic Science

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Cell Collection and Processing

Clinical Autologous Transplantation: Results

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases

10:30 AM-12:00 PM

Regulation of Iron Metabolism

Hemoglobinopathies, Excluding Thalassemia – Clinical

Disorders of Coagulation or Fibrinolysis

Oncogenes and Tumor Suppressors

Acute Myeloid Leukemia: Clinical Studies

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes – Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases

2:45 PM-4:15 PM

Thalassemia and Globin Gene Regulation

Granulocytes, Monocytes and Macrophages

Pathophysiology of Thrombosis

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Bone Marrow Failure

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Myelodysplastic Syndromes – Basic and Translational Studies

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Health Services and Outcomes Research – Non-Malignant Conditions

4:30 PM-6:00 PM

Thalassemia and Globin Gene Regulation

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Myeloproliferative Syndromes: Clinical

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Malignant Stem and Progenitor Cells

Adoptive Immunotherapy

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Chemical Biology and Experimental Therapeutics

Health Services and Outcomes Research – Malignant Diseases

Health Services and Outcomes Research – Malignant Diseases

6:00 PM-8:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia – Clinical

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Platelet Activation and Biochemistry

Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis: Epigenetic, Transcriptional and Translational Control

Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Bone Marrow Failure

Chromosomal Rearrangements and DNA Repair

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Hodgkin Lymphoma: Biology, excluding Therapy

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes – Basic and Translational Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Malignant Stem and Progenitor Cells

Experimental Transplantation: Basic Biology, Engraftment and Disease Activity

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

Adoptive Immunotherapy

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Chemical Biology and Experimental Therapeutics

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases

6:15 PM-7:45 PM

Granulocytes, Monocytes and Macrophages

Antithrombotic Therapy

Hematopoietic Stem and Progenitor Biology

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Myelodysplastic Syndromes – Clinical Studies

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Autologous Transplantation: Results